Non-hodgkin's lymphomas in Saskatchewan: a clinicopathologic study

Area of Science:

• Hematology
• Oncology
• Clinical Pathology

Background:

• Non-Hodgkin's lymphomas (NHL) are a diverse group of lymphoid malignancies.
• Accurate classification and staging are crucial for determining prognosis and guiding treatment.

Purpose of the Study:

• To analyze the relationship between histopathologic type, clinical stage, and survival in previously untreated non-Hodgkin's lymphomas.
• To evaluate the utility of Rappaport and Ann Arbor classifications in predicting patient outcomes.

Main Methods:

• Retrospective clinical study of 208 untreated patients with non-Hodgkin's lymphomas.
• Classification and staging using Rappaport, Winter, and Hicks criteria and Ann Arbor clinical staging.
• Survival analysis correlated with histopathologic type and disease stage.

Main Results:

• Nodular lymphomas (22%) and diffuse lymphomas (78%) showed distinct demographic patterns.
• Diffuse lymphomas had a bimodal age distribution, with increased incidence in those over 69 years.
• Patients with nodular (follicular) and diffuse lymphocytic well-differentiated lymphomas had significantly better survival (P < 0.05) compared to other diffuse types.

Conclusions:

• Histopathologic subtype is a critical determinant of survival in non-Hodgkin's lymphoma.
• Nodular lymphomas represent a distinct entity requiring specific management strategies.
• Understanding the biologic behavior of different lymphoma subtypes is essential for effective therapeutic planning.